tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kennen Mackay, 141 are a BUY (64.38%), 77 are a HOLD (35.16%), 1 are a SELL (0.46%).
Analyst Kennen Mackay, carries an average stock price target met ratio of 62.37% that have a potential upside of 30.54% achieved within 333 days. Previously, Kennen Mackay worked at RBC, CREDIT SUISSE, CITI.
Kennen Mackay’s has documented 415 price targets and ratings displayed on 33 stocks. The coverage was on Healthcare, Industrials, Consumer Defensive sectors.
Most recent stock forecast was given on NUVB, Nuvation Bio at 17-Apr-2024.
Analyst best performing recommendations are on ANAB (ANAPTYSBIO).
The best stock recommendation documented was for ANAB (ANAPTYSBIO) at 4/4/2018. The price target of $86 was fulfilled within 2 days with a profit of $8.35 (8.85%) receiving and performance score of 44.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Oct-2017
$20
$14.39 (256.51%)
$20
3 months 18 days ago
(28-May-2026)
0/13 (0%)
$14.22 (246.02%)
Buy Since 29-Apr-2025
$19
$13.39 (238.68%)
$20
10 months 3 days ago
(12-Nov-2025)
0/3 (0%)
$14.06 (284.62%)
Buy Since 02-Jun-2025
$20
$14.39 (256.51%)
$19
1 years 1 months ago
(15-Aug-2025)
0/2 (0%)
$12.87 (180.50%)
Buy Since 30-May-2024
$20
$15.55 (349.44%)
$21
1 years 3 months 30 days ago
(16-May-2025)
0/2 (0%)
$13.9 (227.87%)
Buy Since 19-Feb-2025
$15
$9.39 (167.38%)
$15
1 years 5 months 22 days ago
(24-Mar-2025)
0/2 (0%)
$9.88 (192.97%)
